Links to all GeneRIF Items | 94025 |
PubMed (Gene Name) | Literature evidence |
|---|---|
| 17413979 (MUC16) | Our results suggest that an immunohistochemical panel consisting of TTF-1, CEA, CA-125, and OCT-4 is helpful in distinguishing most pulmonary and ovarian carcinomas with clear cell features. |
| 19383238 (MUC16) | The utility of the tumour markers carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 19-9, carbohydrate antigen 15-3, alpha-fetoprotein and human chorionic gonadotropin for the diagnosis solitary pulmonary nodules, was investigated. |
| 22674301 (MUC16) | Data show that the prognostic values of CA125, CA19.9, neuron-speci fi c enolase (NSE), and squamous cell carcinoma antigen (SCC) for stage I non-small-cell lung cancer NSCLC are limited. |
| 23712355 (MUC16) | High levels of neuron-specific enolase (NSE), carbohydrate antigen 125 (CA125) and squamous cell carcinoma antigen (SCC) were detected in 306 (63.6%), 89 (18.5%) and 125 (26.0%) non-small cell lung cancer patients, respectively. |
| 24913812 (MUC16) | The elevation of CA125 before treatment predicts a poor prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy. |
| 26163610 (MUC16) | Elevation of serum CA125 is associated with Non-small Cell lung cancer. |
| 26560853 (MUC16) | CEA, NSE, CA125 and pro-GRP could serve as biomarkers for SCLC, and CEA and CYFRA21-1 could serve as biomarkers for NSCLC. Pro-GRP, CA125 and CEA were related to the clinical stages of lung cancer |
| 27002010 (MUC16) | Serum CA 12-5 level and TNM status predict the long-term prognosis of resected primary adenosquamous carcinoma of the lung. |
| 29797475 (MUC16) | Studied levels of mucin 16 (CA125), adenosine deaminase and midkine as tumor markers in nonsmall cell lung cancer-associated malignant pleural effusion. |
| 30672447 (MUC16) | The significance of combined serum CEA and CA125 detection in lung cancer is confirmed. |
| 30790454 (MUC16) | These results provide a potential, novel biomarker for lung cancer progression, in particular, protease resistant MUC16 peptides; and suggest a possible mechanism of immune escape entailing the reduction of mutant peptides available for HLA class I binding. |
| 33056994 (MUC16) | ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells. |
| 33382999 (MUC16) | cancer antigen-125 is a predictor of mortality in patients with pulmonary arterial hypertension. |